doi: 10.3389/fimmu.2026.1773284 Received 22 December 2025 Revised 13 February 2026 Accepted 05 March 2026 Published 26 March 2026 Volume 17 - 2026 Edited by Sudhir Gupta, University of California, Irvine, United States Reviewed by Charlotte Slade, The University of Melbourne, Australia Anupriya Kaur, Post Graduate Institute of Medical Education and Research (PGIMER), India Updates Copyright 2026 Jans, Al, Bouman, Geelen, Kleefstra and Placek
Improved Mood Balance These injections may contribute to enhanced neurotransmitter activity, which can help support emotional balance
Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Drug Reactions BPC-157 has been shown to reduce the adverse effects of NSAIDs, psychiatric drugs, and several cardiac treatments
GLP-1s are a type of incretin-based therapy that works by copying the actions of natural hormones in the body
In a May interview with wellness entrepreneur Gary Brecka, Kennedy elaborated on how he sees the role of the FDA with regards to experimental treatments, including peptides